ANIX vs ECL · rev $210.0K vs P/E 35, rev $4.01B
Anixa Biosciences Inc (ANIX) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Anixa Biosciences Inc (ANIX) is a biotechnology company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported ANIX revenue for 2024-10-31 was $210.0K. Net income was -$12.7M. Revenue was up 0.0% from 2023-10-31 to 2024-10-31. ANIX currently screens at market cap $101.1M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
ANIX currently screens at market cap $101.1M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the ANIX and ECL stock pages for the full models.
Not investment advice.